Analysis of Nosocomial Infection in a Cancer Hospital from 2019 to 2021
10.13471/j.cnki.j.sun.yat-sen.univ（med.sci）.20230409.002
- VernacularTitle:2019~2021年某肿瘤专科医院院内感染情况分析
- Author:
Li-hua HUANG
1
;
Jiao LIU
1
;
Xue-er PENG
1
;
Chen-guang LI
1
;
Hao-zhi ZHU
1
;
Huan LI
1
;
Chuang-zhong DENG
1
Author Information
1. Sun Yat-sen University Cancer Center//State Key Laboratory of Oncology in South China， Guangzhou， 510060， China
- Publication Type:Journal Article
- Keywords:
cancer patients;
nosocomial infection;
multidrug-resistant bacteria;
prevention and control
- From:
Journal of Sun Yat-sen University(Medical Sciences)
2023;44(4):697-703
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo understand the situation of nosocomial infection in cancer hospitals and its changing trend， so as to provide a basis for adjusting the focus of nosocomial infection prevention and control in cancer hospitals. MethodsData of nosocomial infection quality control indices of Sun Yat-sen University Cancer Center from 2019 to 2021 were obtained through the nosocomial infection monitoring system， and the changes of these indices across the three years were analyzed by Chi-square test and Cochran-Armitage trend test. ResultsFrom 2019 to 2021， the incidence rates of nosocomial infection in this hospital were 0.80%， 0.78% and 0.57%， which decreased significantly year by year （P<0.001）. Among them， surgical site and respiratory system infection were more common， accounting for 35.75% and 31.08%， respectively. Gram-negative bacteria and fungi were the main pathogens. The incidence rate of multidrug-resistant bacteria in hospital increased year by year， from 0.08‰ to 0.14‰ （P<0.001）， among which methicillin-resistant staphylococcus aureus， carbapenem-resistant Enterobacter and bacteria producing ultra-broad spectrum β-lactamase （ESBLs） bacteria increased significantly. The incidence rates of three-tube associated infections were no different across 3 years （P>0.05）， which were still at high levels. ConclusionFrom 2019 to 2021， the prevention and control of nonsocomial infection in the cancer hospital has been improved overall. Meanwhile， the infections of respiratory system and surgical sites， ESBLs related multidrug-resistant bacteria and three-tube are weak links in cancer specialized hospitals， which need to be emphasized and improved.
